HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haryana M Dhillon Selected Research

Docetaxel (Taxotere)

1/2022GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haryana M Dhillon Research Topics

Disease

22Neoplasms (Cancer)
12/2022 - 01/2016
7Cognitive Dysfunction
09/2022 - 12/2015
6Breast Neoplasms (Breast Cancer)
11/2021 - 12/2013
6Neurobehavioral Manifestations
02/2019 - 12/2015
5Fatigue
10/2022 - 12/2015
5Melanoma (Melanoma, Malignant)
09/2020 - 04/2019
3Prostatic Neoplasms (Prostate Cancer)
10/2022 - 01/2022
3Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 12/2015
3Head and Neck Neoplasms (Head and Neck Cancer)
03/2020 - 01/2017
2Inflammation (Inflammations)
09/2022 - 01/2018
2Brain Neoplasms (Brain Tumor)
11/2019 - 08/2019
2Skin Neoplasms (Skin Cancer)
03/2019 - 10/2015
1Disease Progression
10/2022
1Lymphoma (Lymphomas)
09/2022
1Lung Neoplasms (Lung Cancer)
09/2022
1Vomiting
04/2022
1Nausea
04/2022
1Pain (Aches)
02/2021
1Kidney Neoplasms (Kidney Cancer)
01/2021
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2020
1Neoplasm Metastasis (Metastasis)
11/2019
1Confusion (Bewilderment)
01/2017
1Alopecia (Baldness)
11/2016
1Ovarian Neoplasms (Ovarian Cancer)
10/2016
1Rectal Neoplasms (Rectal Cancer)
12/2015
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2015
1Basal Cell Carcinoma (Rodent Ulcer)
10/2015
1Actinic Keratosis
10/2015

Drug/Important Bio-Agent (IBA)

2Hormones (Hormone)IBA
10/2022 - 12/2013
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
2pembrolizumabIBA
05/2019 - 04/2019
2Niacinamide (Nicotinamide)FDA LinkGeneric
03/2019 - 10/2015
1enzalutamideIBA
10/2022
1Docetaxel (Taxotere)FDA Link
01/2022
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2022
1Glutathione Transferase (Glutathione S-Transferase)IBA
01/2022
1ElementsIBA
04/2021
1N-(4-aminophenethyl)spiroperidol (NAPS)IBA
04/2021
1AntiemeticsIBA
02/2021
1mesoglycanIBA
01/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2020
1ibudilastIBA
10/2020
1CytokinesIBA
01/2018
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2018
1cyclo(Arg-Pro) (CI 4)IBA
10/2015
1Anastrozole (Arimidex)FDA LinkGeneric
12/2013
1Plant ExtractsIBA
12/2013
1Letrozole (Femara)FDA LinkGeneric
12/2013
1TamoxifenFDA LinkGeneric
12/2013

Therapy/Procedure

15Drug Therapy (Chemotherapy)
09/2022 - 12/2015
11Radiotherapy
12/2022 - 12/2015
6Therapeutics
09/2022 - 12/2013
4Cognitive Training
10/2019 - 01/2017
3Palliative Care (Palliative Therapy)
09/2022 - 12/2019
3Adjuvant Chemotherapy
03/2021 - 01/2017
3Immunotherapy
09/2020 - 04/2019
2Aftercare (After-Treatment)
01/2022 - 01/2017
2Chemoprevention
03/2019 - 10/2015
1Castration
01/2022
1Polypharmacy
01/2019
1Complementary Therapies (Alternative Medicine)
02/2017
1Neoadjuvant Therapy
12/2015